In 2009, the foreign trade of traditional Chinese medicine revived, and the border small trade became a bright spot

Affected by the international financial crisis, China's foreign trade suffered a severe cold in 2009, with the total import and export volume down 13.9% year on year After experiencing the difficulties in 2008 and the first half of 2009, the import and export situation of the pharmaceutical industry in the second half of 2009 picked up rapidly, forming a contrast with the overall foreign trade situation of China, with the total import and export growth rate reaching 9.8% year-on-year The foreign trade of traditional Chinese medicine has picked up momentum again The total import and export volume has exceeded 2 billion US dollars The year-on-year growth rate ranks first among all kinds of medical commodities (Western medicine, medical equipment and traditional Chinese Medicine), with an increase rate of 14.36%, the highest level since 2007 Among them, the export volume of traditional Chinese medicine products was US $1.46 billion, up 11.72% year-on-year, 3 percentage points higher than that in 2008; the import volume was US $540 million, up 22.14% year-on-year, 1.6 percentage points higher than that in 2008, reaching the highest point in the past six years 1 The foreign trade continued to maintain a surplus, but the export growth rate was 10% lower than the import growth rate In 2009, the foreign trade of traditional Chinese medicine continued to maintain a surplus, with the surplus reaching US $920 million, but the export growth rate was 10% lower than the import growth rate In each single commodity, the trade of plant extracts and traditional Chinese medicine is in surplus, and the export of extracts accounts for 44.8% of the total export of traditional Chinese medicine products, ranking first; the export of Chinese medicine Pieces accounts for 37.92% of the total export of traditional Chinese medicine products, ranking second; the trade of traditional Chinese medicine and health care products is in deficit, and the trade of traditional Chinese medicine is in deficit for the second time after 2008, with a slight increase in the deficit; and In addition to 2006, Jianpin trade has been in deficit since 2003 In 2009, the inverse balance reached 23.145 million US dollars, the highest one 2 General trade is the main mode of import and export of traditional Chinese medicine, while border small trade has become a bright spot From the perspective of trade mode, general trade is still the main mode of import and export of traditional Chinese medicine In 2009, the export of traditional Chinese medicine products by general trade accounted for 83.73% of the total export of traditional Chinese medicine; the import of traditional Chinese medicine products by general trade accounted for 68.97% of the total import of traditional Chinese medicine In the import trade, the import processing trade accounts for 17.14%, and in the export trade, the import processing trade accounts for 7.89% The warehousing and entrepot trade of goods in the bonded area is a characteristic way of importing traditional Chinese medicine In 2009, the volume of traditional Chinese medicine goods imported in this way reached 21754 tons Border small trade is another feature of traditional Chinese medicine export In 2009, the export volume of traditional Chinese medicine commodities reached 31875 tons, which is the most export mode except general trade In 2009, there were 2766 export enterprises of traditional Chinese medicine products Private enterprises became the main force of export, accounting for 41.14% of the total export amount; foreign-funded enterprises accounted for 33.78% of the total export amount; state-owned enterprises withdrew from the first corps of traditional Chinese medicine products, accounting for only 24.87% of the total export amount It is worth noting that among the private enterprises, the export volume of private enterprises accounts for more than 90% There are 1380 enterprises engaged in the import of traditional Chinese medicine products, of which the import momentum of three foreign-funded enterprises is strong, with the import amount reaching US $270 million, accounting for 49.73% The wholly foreign-owned enterprises are the main force among the three foreign-funded enterprises, with the import amount as high as US $190 million; the import amount of private enterprises is US $210 million, accounting for 39.07%; the import amount of state-owned enterprises is only US $60 million, accounting for 11.18%.